oral decitabine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for oral decitabine, covering 2023-05-31 to 2023-05-31. Get the full timeline:
Most recent: Clinical Trial Update: Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas [Phase 1, Phase 2]